329 related articles for article (PubMed ID: 24799499)
41. Negative regulation of T cell receptor signaling by Siglec-7 (p70/AIRM) and Siglec-9.
Ikehara Y; Ikehara SK; Paulson JC
J Biol Chem; 2004 Oct; 279(41):43117-25. PubMed ID: 15292262
[TBL] [Abstract][Full Text] [Related]
42. Engagement of myelomonocytic Siglecs by tumor-associated ligands modulates the innate immune response to cancer.
Läubli H; Pearce OM; Schwarz F; Siddiqui SS; Deng L; Stanczak MA; Deng L; Verhagen A; Secrest P; Lusk C; Schwartz AG; Varki NM; Bui JD; Varki A
Proc Natl Acad Sci U S A; 2014 Sep; 111(39):14211-6. PubMed ID: 25225409
[TBL] [Abstract][Full Text] [Related]
43. Group B Streptococcus Biofilm Regulatory Protein A Contributes to Bacterial Physiology and Innate Immune Resistance.
Patras KA; Derieux J; Al-Bassam MM; Adiletta N; Vrbanac A; Lapek JD; Zengler K; Gonzalez DJ; Nizet V
J Infect Dis; 2018 Oct; 218(10):1641-1652. PubMed ID: 29868829
[TBL] [Abstract][Full Text] [Related]
44. Differences in the constitutive and SIV infection induced expression of Siglecs by hematopoietic cells from non-human primates.
Jaroenpool J; Rogers KA; Pattanapanyasat K; Villinger F; Onlamoon N; Crocker PR; Ansari AA
Cell Immunol; 2007; 250(1-2):91-104. PubMed ID: 18331725
[TBL] [Abstract][Full Text] [Related]
45. Constitutively expressed Siglec-9 inhibits LPS-induced CCR7, but enhances IL-4-induced CD200R expression in human macrophages.
Higuchi H; Shoji T; Iijima S; Nishijima K
Biosci Biotechnol Biochem; 2016 Jun; 80(6):1141-8. PubMed ID: 26923638
[TBL] [Abstract][Full Text] [Related]
46. Antimicrobial peptide response to group B Streptococcus in human extraplacental membranes in culture.
Boldenow E; Jones S; Lieberman RW; Chames MC; Aronoff DM; Xi C; Loch-Caruso R
Placenta; 2013 Jun; 34(6):480-5. PubMed ID: 23562109
[TBL] [Abstract][Full Text] [Related]
47. A balance between B cell receptor and inhibitory receptor signaling controls plasma cell differentiation by maintaining optimal Ets1 levels.
Luo W; Mayeux J; Gutierrez T; Russell L; Getahun A; Müller J; Tedder T; Parnes J; Rickert R; Nitschke L; Cambier J; Satterthwaite AB; Garrett-Sinha LA
J Immunol; 2014 Jul; 193(2):909-920. PubMed ID: 24929000
[TBL] [Abstract][Full Text] [Related]
48. The CiaR response regulator in group B Streptococcus promotes intracellular survival and resistance to innate immune defenses.
Quach D; van Sorge NM; Kristian SA; Bryan JD; Shelver DW; Doran KS
J Bacteriol; 2009 Apr; 191(7):2023-32. PubMed ID: 19114476
[TBL] [Abstract][Full Text] [Related]
49. Distinct Group B
Flaherty RA; Aronoff DM; Gaddy JA; Petroff MG; Manning SD
Infect Immun; 2021 Apr; 89(5):. PubMed ID: 33558317
[TBL] [Abstract][Full Text] [Related]
50. Sialic acid-binding immunoglobulin-like lectin 8 (Siglec-8) is an activating receptor mediating β
Carroll DJ; O'Sullivan JA; Nix DB; Cao Y; Tiemeyer M; Bochner BS
J Allergy Clin Immunol; 2018 Jun; 141(6):2196-2207. PubMed ID: 28888781
[TBL] [Abstract][Full Text] [Related]
51. A Guillain-Barré syndrome-associated SIGLEC10 rare variant impairs its recognition of gangliosides.
Alborzian Deh Sheikh A; Gomaa S; Li X; Routledge M; Saigoh K; Numoto N; Angata T; Hitomi Y; Takematsu H; Tsuiji M; Ito N; Kusunoki S; Tsubata T
J Autoimmun; 2021 Jan; 116():102571. PubMed ID: 33223341
[TBL] [Abstract][Full Text] [Related]
52. Colonic epithelial cells express specific ligands for mucosal macrophage immunosuppressive receptors siglec-7 and -9.
Miyazaki K; Sakuma K; Kawamura YI; Izawa M; Ohmori K; Mitsuki M; Yamaji T; Hashimoto Y; Suzuki A; Saito Y; Dohi T; Kannagi R
J Immunol; 2012 May; 188(9):4690-700. PubMed ID: 22467657
[TBL] [Abstract][Full Text] [Related]
53. Common determinants of severe Covid-19 infection are explicable by SARS-CoV-2 secreted glycoprotein interaction with the CD33-related Siglecs, Siglec-3 and Siglec-5/14.
Murch SH
Med Hypotheses; 2020 Nov; 144():110168. PubMed ID: 33254494
[TBL] [Abstract][Full Text] [Related]
54. A novel function of Siglec-9 A391C polymorphism on T cell receptor signaling.
Cheong KA; Chang YS; Roh JY; Kim BJ; Kim MN; Park YM; Park HJ; Kim ND; Lee CH; Lee AY
Int Arch Allergy Immunol; 2011; 154(2):111-8. PubMed ID: 20733319
[TBL] [Abstract][Full Text] [Related]
55. Expression of ligands for Siglec-8 and Siglec-9 in human airways and airway cells.
Jia Y; Yu H; Fernandes SM; Wei Y; Gonzalez-Gil A; Motari MG; Vajn K; Stevens WW; Peters AT; Bochner BS; Kern RC; Schleimer RP; Schnaar RL
J Allergy Clin Immunol; 2015 Mar; 135(3):799-810.e7. PubMed ID: 25747723
[TBL] [Abstract][Full Text] [Related]
56. Siglecs in innate immunity.
Crocker PR
Curr Opin Pharmacol; 2005 Aug; 5(4):431-7. PubMed ID: 15955740
[TBL] [Abstract][Full Text] [Related]
57. CD33-related siglecs as potential modulators of inflammatory responses.
Crocker PR; McMillan SJ; Richards HE
Ann N Y Acad Sci; 2012 Apr; 1253():102-11. PubMed ID: 22352893
[TBL] [Abstract][Full Text] [Related]
58. Group B streptococcal capsular sialic acids interact with siglecs (immunoglobulin-like lectins) on human leukocytes.
Carlin AF; Lewis AL; Varki A; Nizet V
J Bacteriol; 2007 Feb; 189(4):1231-7. PubMed ID: 16997964
[TBL] [Abstract][Full Text] [Related]
59. Probing the cis interactions of the inhibitory receptor Siglec-7 with alpha2,8-disialylated ligands on natural killer cells and other leukocytes using glycan-specific antibodies and by analysis of alpha2,8-sialyltransferase gene expression.
Avril T; North SJ; Haslam SM; Willison HJ; Crocker PR
J Leukoc Biol; 2006 Oct; 80(4):787-96. PubMed ID: 16857734
[TBL] [Abstract][Full Text] [Related]
60. Reduced Siglec-7 expression on NK cells predicts NK cell dysfunction in primary hepatocellular carcinoma.
Tao L; Wang S; Yang L; Jiang L; Li J; Wang X
Clin Exp Immunol; 2020 Aug; 201(2):161-170. PubMed ID: 32319079
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
